The ENT Endoscopic Surgery Devices segmentation by application distinguishes three principal uses: diagnostic, therapeutic and research. Diagnostic devices, accounting for roughly 35% of market revenue, enable visualization of the nasal cavity, larynx and ear structures, supporting early disease detection and pre‑operative planning. Therapeutic applications dominate the market with an estimated 45% share, driven by procedures such as functional endoscopic sinus surgery, laser ablation and tumor resection, where device reliability directly influences surgical outcomes and procedural throughput. The remaining 20% pertains to research usage, encompassing academic and clinical trials that test novel endoscopic technologies, generate safety data, and foster innovation pipelines. Together, these application categories shape the overall market size by dictating demand patterns, pricing structures, and investment focus across hospitals, ambulatory surgery centers and research institutions. The distribution reflects the clinical priority hierarchy, with therapeutic needs steering the bulk of capital expenditure in the ENT endoscopic ecosystem.